These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 5522670

  • 21. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
    Hunyi L.
    Ther Hung; 1978; 26(2):77-80. PubMed ID: 684660
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
    Fisanovich TI, Tolstova LG.
    Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of experimental and human athero- sclerosis by a bradykinin antagonist, pyridinol carbamate. (Preliminary report)].
    Shimamoto T, Numano F, Fujita T, Atsumi T.
    Rev Atheroscler (Paris); 1967 Sep; 9(2):294-306. PubMed ID: 6064255
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
    Grodzińska L, Basista M, Byrska-Danek A, Kostka-Trabka E.
    Pol Tyg Lek; 1967 Sep; 39(25-26):879-81. PubMed ID: 6387654
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of occlusive diseases of the arteries in the limbs with pyridinol-carbamate.
    Matsumoto K, Sato K, Tanaka S.
    Jpn Heart J; 1966 Jan; 7(1):87-93. PubMed ID: 5295647
    [No Abstract] [Full Text] [Related]

  • 31. [Short-term heparin therapy in obliterating arteriopathies of the lower limbs].
    Arrigo F, Coglitore S, Giannetto M, Bramanti O, Barbera C, Consolo F.
    Boll Soc Ital Cardiol; 1977 Jan; 22(3):273-82. PubMed ID: 617274
    [No Abstract] [Full Text] [Related]

  • 32. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V.
    Minerva Med; 1975 Jan 13; 66(2):55-65. PubMed ID: 1113917
    [Abstract] [Full Text] [Related]

  • 33. Treatment of atherosclerosis obliterans with pyridinolcarbamate.
    Atsumi T, Motomiya T, Isokane N, Shimamoto T.
    Jpn Heart J; 1971 Jul 13; 12(4):335-46. PubMed ID: 5314713
    [No Abstract] [Full Text] [Related]

  • 34. [The effect of eledoisin on the rheogram in arteriosclerosis obliterans].
    Szám I, Kusztos D, Csapó G.
    Arzneimittelforschung; 1966 Dec 13; 16(12):1671-3. PubMed ID: 6014806
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Experiences with venous-occlusion-rheography for the quantitative measurement of the limb blood supply].
    Olesch K.
    Med Klin; 1970 Jul 31; 65(31):1405-11. PubMed ID: 5513615
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.